Dana E Moseson from Oakdale, CT, age 41

Dana Moseson Phones & Addresses

Oakdale, CT
West Lafayette, IN
Washington, DC
Havertown, PA
Havertown, PA
Nora, VA
Bethlehem, PA
New Milford, NJ
University Park, PA

Work

Company:

Emerson resources
Dec 2011
Address:

Norristown, PA
Position:

Senior formulation scientist

Education

Degree:

B.S.
School / High School:

Pennsylvania State University-University Park Campus
2001 to 2005
Specialities:

Life Science

Skills

Gmp • Formulation • Sop • Pharmaceutical Industry • Design of Experiments • R&D • Quality Assurance • Product Development • Pharmaceutics • Hplc • Training • Novel Solutions To Formulation and Proce... • Quality System • Quality Control • Clinical Trials • Technology Transfer • Manufacturing • Validation • Change Control • Capa • Internal Audit • Document Editing • Risk Management • Investigation • Techniques For Solubility Enhancement • Modified and Controlled Release • Tablet Compaction Optimization • Specialty Coating Applications • Theoretical and Experiential Knowledge o... • Design and Execution of Mixture and Fact... • Scale Up and Technology Transfer • Color Matching By Cielab Color Space • Cold Chain • Supplier Qualification • Oos/Oot • Iq/Oq/Pq • Environmental Monitoring • Deviations • Stability Programs • Quality Agreements

Interests

Children

Industries

Pharmaceuticals

Us Patents

Controlled-Release Solid Dosage Forms Of Mesalamine
view source
US Patent:

20190231699, Aug 1, 2019
Filed:

Aug 31, 2018
Appl. No.:

16/119362
Inventors:

- Bridgewater NJ, US
John Christopher Carter - Keswick, CA
Dana Elaine Moseson - West Lafayette IN, US
Stephen Paul Levine - Norristown PA, US
Assignee:

Santarus, Inc. - Bridgewater NJ
International Classification:

A61K 9/20
A61K 31/58
A61K 9/48
A61K 31/606
A61K 9/28
Abstract:

Described are controlled-release solid dosage forms of mesalamine. In one aspect of the invention the controlled-released solid dosage forms of mesalamine are capsules comprising a plurality of coated mini-tablets. Another aspect of the invention related to a methods of treating a patient suffering from inflammatory bowel disease, comprising the step of administering to the patient a therapeutically effective amount of the solid dosage form. The invention also relates to methods of inducing remission of inflammatory bowl disease and maintaining remission of inflammatory bowel disease. In certain aspects, the inflammatory bowel disease is ulcerative colitis or Crohn's disease.

Resumes

Phd Candidate, Industrial And Physical Pharmacy

view source

Location:

3342 Maitland Dr, West Lafayette, IN

Industry:

Pharmaceuticals

Work:

Emerson Resources - Norristown, PA since Dec 2011
Senior Formulation Scientist
Emerson Resources - Norristown, PA Aug 2006 - May 2012
Formulation Scientist
Reckitt Benckiser May 2005 - Aug 2006
Product Development Scientist
Pfizer May 2004 - Aug 2004
Intern in Analytical Research & Development
McNeil Consumer & Specialty Pharmaceuticals Jun 2003 - Jan 2004
R&D Co-op (Intern)

Education:

Pennsylvania State University-University Park Campus 2001 - 2005
B.S., Life Science

Skills:

Gmp
Formulation
Sop
Pharmaceutical Industry
Design of Experiments
R&D
Quality Assurance
Product Development
Pharmaceutics
Hplc
Training
Novel Solutions To Formulation and Process Challenges
Quality System
Quality Control
Clinical Trials
Technology Transfer
Manufacturing
Validation
Change Control
Capa
Internal Audit
Document Editing
Risk Management
Investigation
Techniques For Solubility Enhancement
Modified and Controlled Release
Tablet Compaction Optimization
Specialty Coating Applications
Theoretical and Experiential Knowledge of the Full Range of Excipients
Design and Execution of Mixture and Factorial Design of Experiments
Scale Up and Technology Transfer
Color Matching By Cielab Color Space
Cold Chain
Supplier Qualification
Oos/Oot
Iq/Oq/Pq
Environmental Monitoring
Deviations
Stability Programs
Quality Agreements

Interests: